Skip to content

Ovarian Cancer Health Center

Font Size

Ovarian Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Summary of Evidence

Note: Separate PDQ summaries on Ovarian Cancer Screening and Ovarian Epithelial Cancer Treatment are also available.

Oral Contraceptives: Benefits

Recommended Related to Ovarian Cancer

Stage III and Stage IV Ovarian Epithelial Cancer Treatment

Treatment options for patients with all stages of ovarian epithelial cancer have consisted of surgery followed by chemotherapy. Surgery Patients diagnosed with stage III and stage IV disease are treated with surgery and chemotherapy; however, the outcome is generally less favorable for patients with stage IV disease. The role of surgery for patients with stage IV disease is unclear, but in most instances, the bulk of the disease is intra-abdominal, and surgical procedures similar to those...

Read the Stage III and Stage IV Ovarian Epithelial Cancer Treatment article > >

Based on solid evidence, oral contraceptive use is associated with a decreased risk of developing ovarian cancer.

Description of the Evidence

  • Study Design: Evidence obtained from multiple case-control and cohort studies.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: A relative risk (RR) reduction of about 50% overall with a dose response ranging from 5% to 10% RR reduction per year of use to maximum RR reductions of up to 80%.
  • External Validity: Good.

Oral Contraceptives: Harms

Based on solid evidence, combined current use of estrogen/progestogen oral contraceptive use is associated with an increased risk of venous thromboembolism. Oral contraceptives are not associated with a long-term increased risk of breast cancer but may be associated with a short-term increased risk while a woman is taking oral contraceptives. The risk of breast cancer declines with time since last use.

Description of the Evidence

  • Study Design: Evidence obtained from observational studies.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: The risks may vary by preparation. Overall, the absolute risk of venous thromboembolism is about three events per 10,000 women per year while taking oral contraceptives. The risk is increased by smoking. Breast cancer risk among long-term (>10 years) current users is estimated at one extra case per year per 100,000 women. The risk dissipates with time since last use.
  • External Validity: Good.

Prophylactic Oophorectomy: Benefits

Based on solid evidence, prophylactic bilateral oophorectomy is associated with a decreased risk of ovarian cancer. Peritoneal carcinomatosis has been reported following prophylactic removal of the ovaries. Prophylactic oophorectomy, along with salpingo-oophorectomy, is generally reserved for women at high risk of developing ovarian cancer, such as women who have a deleterious mutation in a BRCA1 or BRCA2 gene.

Description of the Evidence

  • Study Design: Evidence obtained from multiple case-control and cohort studies.
  • Internal Validity: Good.
  • Consistency: Good.
  • Magnitude of Effects on Health Outcomes: 90% reduction in risk of ovarian cancer observed among women with a BRCA1 or BRCA2 mutation.
  • External Validity: Good.
    1|2
    Next Article:

    Today on WebMD

    Ovarian cancer illustration
    What are the symptoms?
    doctory with x-ray
    Get to know the Symptoms.
     
    cancer cell
    HPV is the top cause. Find out more.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    Integrative Medicine Cancer Quiz
    QUIZ
    Lifestyle Tips for Depression Slideshow
    SLIDESHOW
     
    Screening Tests for Women
    Slideshow
    Graphic of ovaries within reproductive system
    VIDEO
     
    Ovarian Cancer Marker
    VIDEO
    Pets Improve Your Health
    SLIDESHOW
     
    Vitamin D
    SLIDESHOW
    Healthy meal with salmon
    Article